HIVinfo.nih.gov offers access to the latest, federally approved HIV/AIDS medical practice guidelines, HIV treatment and prevention clinical trials, and other research information for health care providers, researchers, people affected by HIV/AIDS, and the general public.
HIVinfo.nih.gov, a service of the U.S. Department of Health and Human Services (HHS), is maintained by the Office of AIDS Research (OAR), which is part of the National Institutes of Health (NIH). OAR coordinates HIV/AIDS research across the National Institutes of Health (NIH). The NIH provides the largest public investment in HIV/AIDS research globally.
HIVinfo.nih.gov is 100% federally funded and sponsored by the Office of AIDS Research (OAR).
[Editor's Note from TheBody: This information has been cross-posted from HIVinfo's "About" page]
Latest by HIVinfo
Anyone can get HIV, including older people, HIVinfo reports in this fact sheet. According to the CDC, in 2016, nearly half of the people in the United States living with diagnosed HIV were aged 50 and older.
If you're living with HIV in the U.S., this federal government fact sheet provides a brief breakdown of options that can help you find a health care provider, pay for your medicines, locate affordable housing, and get help with mental health issues.
Treatment adherence includes starting HIV treatment, keeping all medical appointments, and taking HIV medicines every day as prescribed. For people with HIV, treatment adherence is key to staying healthy.
Key PointsHIV medicines help people with HIV live longer, healthier lives. Sometimes HIV medicines can also cause side effects. Most side effects from HIV medicines are manageable, but a few can be serious.Overall, the benefits of HIV medicines far o...
Other Names: Depakene, Depakote, Depakote ER, Epival, VPA, divalproex sodium, valproate Drug Class: Latency-Reversing Agents Molecular Formula: C8 H16 O2 Registry Number: 99-66-1 (CAS) Chemical Name: 2-propylpentanoic acid Chemical Class: O...
Brand Name: Kaletra Other Name(s): LPV / RTV, LPV/r, ritonavir-boosted lopinavir Drug Class: Protease Inhibitors
Brand Name: Isentress Other Name(s): RAL, raltegravir potassium Drug Class: Integrase Inhibitors
Brand Name: Prezista Other Name(s): DRV, darunavir ethanolate Drug Class: Protease Inhibitors
Brand Name: Epzicom Other Name(s): ABC/3TC, abacavir sulfate/lamivudine Drug Class: Nucleoside Reverse Transcriptase Inhibitors
Brand Name: Atripla Other Name(s): EFV/FTC/TDF, efavirenz/emtricitabine/tenofovir DF Drug Class: Combination Drugs